This AI spots dangerous blood cells doctors often miss

Researchers have developed a generative AI system capable of analyzing blood cells with greater accuracy and confidence than human experts, including the detection of subtle abnormalities associated with leukemia and other hematologic malignancies. The system not only identifies rare cell morphologies that clinicians may overlook, but also quantifies its own uncertainty, flagging cases where additional expert review is warranted. This dual capability — high diagnostic precision combined with built-in calibration of confidence — positions the tool as a promising clinical decision-support aid in hematology laboratories. While the results demonstrate strong analytical performance, broader clinical validation and regulatory clearance will be needed before routine deployment in patient care.